...
首页> 外文期刊>Archives of clinical infectious diseases. >Molecular Detection of Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Isolates from Lorestan Province, Iran from 2014 to 2017
【24h】

Molecular Detection of Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Isolates from Lorestan Province, Iran from 2014 to 2017

机译:2014年至2017年劳斯坦省洛斯坦省分枝杆菌分离株中的异烟肼和利福平抗性的分子检测

获取原文
           

摘要

Background: A rise in multidrug-resistant tuberculosis (MDR-TB), which is defined as the resistance to the two most effective firstline therapeutic drugs, Isoniazid (INH) and Rifampin (RIF), threatens global public health worldwide. Resistance of Mycobacterium tuberculosis to INH results from mutations in several genes most commonly in katG gene, and resistance to RIF is due to mutations in rpoB gene. Therefore, rapid diagnosis of MDR-TB is of high importance in controlling the disease progress and outcome. The accurate detection of the resistant TB strains can be accelerated by developing molecular tests. Objectives: The aim of the present local study was to isolate MDR-TB from the patients who were the residents in the west of Iran and examination the frequency of MDR-TB between patients of Lorestan province for the first time and assess the mutations in the regions related to RIF/INH resistance via PCR and sequencing methods. Methods: In this study, 106 isolates of M. tuberculosis were selected in health centers of Lorestan, Iran from 2014 to 2017. After culturing M. tuberculosis isolates on L?wenstein-Jensen medium, classical susceptibility testing proportional method against INH and RIF was performed. After DNA extraction, PCR and sequencing were used to detect mutations related to RIF and INH resistance. Results: The results demonstrated 3.8%, 0.9%, and 0.9% frequency for INH RIF, INH and RIF resistance, respectively. Importantly, 4 out of 6 isolates harbored mutations in codon290 of katG gene. Also, these isolates contained mutations in codon339 of rpoB gene. No mutation was observed in inhA gene of M. tuberculosisisolates. Conclusions: The results suggest that molecular techniques can be used as a rapid method for the identification of drug resistance in clinical isolates of M. tuberculosis. DNA sequencing has a high sensitivity for the detection of resistance mutations to RIF and INH in MDR-TB cases. Also, the results showed that the most frequent resistance associated-mutations occurred in codon290 of katG and codon 339 rpoB gene segments.
机译:背景:多药抗性结核(MDR-TB)的升高,其定义为抗于两种最有效的第一条治疗药物,异烟肼(INH)和利福平(RIF),威胁全球全球公共卫生。结核分枝杆菌对INH的抗性导致在KATG基因中最常见的几种基因中的突变,以及对RIF的抗性是由于RPOB基因的突变。因此,MDR-TB的快速诊断在控制疾病进展和结果方面具有高度重要性。通过开发分子试验,可以加速抗性TB菌株的精确检测。目的:本地本地研究的目的是将MDR-TB与伊朗西部居民的患者分离,并首次考试洛尔斯坦省患者的MDR-TB频率,并评估突变通过PCR和测序方法与RIF / INH电阻相关的区域。方法:在本研究中,从2014年到2017年,伊朗洛尔斯坦的卫生中心选择了106分离株。在2014年至2017年中,在伊朗劳斯坦的卫生中心中选择。表演。 DNA提取后,使用PCR和测序检测与RIF和INH抗性有关的突变。结果:结果分别显示了3.8%,0.9%和0.9%的频率,分别为INH RIF,INH和RIF电阻。重要的是,6分中的4分离出Katg基因的Codon290中的患者突变。此外,这些分离含有RPOB基因的Codon339中的突变。在结核菌isolates的Ina基因中没有观察到突变。结论:结果表明,分子技术可用作鉴定临床分离株抗染色菌染液的快速方法。 DNA测序对MDR-TB病例中的RIF和INH检测抗性突变具有高灵敏度。此外,结果表明,在KATG和密码子339RPOB基因区段的Codon290中发生了最常见的抗性相关突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号